Imagen de Portada

Activation of ZIC family genes in CNS metastasis in humans with breast cancer.

Fuente: Zenodo

Guardado en:

Detalles Bibliográficos
Autor principal:	Mamoor, Shahan
Formato:	Recurso digital
Publicado:	Zenodo 2025
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

BCL2L1 induction in metastasis to the brain in humans with breast cancer.
por: Mamoor, Shahan
Publicado: (2025)

The homeobox transcription factor TCF7 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
por: Mamoor, Shahan
Publicado: (2025)

The homeobox transcription factor MEOX1 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: AFM.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: HHEX.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: BAAT.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: SRC.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: ENOPH1.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: SHPK.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: MTFP1.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: CDK7.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: MINPP1.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: WNK3.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: PANK1.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: CXXC5.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: FJX1.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: HOXB6.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: RPL19.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: PFKFB4.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: DUT.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: SHMT2.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: AIM1.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: MSL1.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ADGRF1.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CD80.
por: Mamoor, Shahan
Publicado: (2025)

Phosphatase targeting in HER2+ breast cancer to prevent and treat CNS disease: PTPN13.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDK4.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CNTNAP2.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CPAMD8.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDC45.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ENPP3.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CMC2.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: DNAAF5.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: EFNA4.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CHORDC1.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: DEPDC1.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MTF1.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: NFATC1.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: GDF5.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: ATG13.
por: Mamoor, Shahan
Publicado: (2025)